Request Deal Involvement
Amgen completed the acquisition of ChemoCentryx for $3.7bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Goldman Sachs
legal advisors to financial advisors
Sullivan & Cromwell
legal advisors
Latham & Watkins
legal advisors
Wachtell Lipton Rosen & Katz
financial advisors
PJT Partners
or
Principals
target
CHEMOCENTRYX INC
bidder
AMGEN INC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite